• October 8, 2012, Letter to the FDA from Richard Blumenthal (D-Conn.) regarding the NECC fungal meningitis outbreak.

http://www.blumenthal.senate.gov/newsroom/press/release/blumenthal-calls-for-stronger-federal-oversight-of-compounding-pharmacies-that-manufacture-drugs

  • October 9, 2012, Letter to the FDA from Rep. John D. Dingell regarding the NECC fungal meningitis outbreak.

http://dingell.house.gov/sites/dingell.house.gov/files/20121009%20Letter%20to%20FDA%20Multistate%20Meningitis%20Outbreak.pdf

  • October 9, 2012, Letter to the CDC from Rep. Fred Upton and the Committee on Energy and Commerce.

http://energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/letters/20121009CDC.pdf

  • October 10, 2012, letter to the FDA from Rep. Edward J. Markey (D-Mass).
  • October 12, 2012, Letter to FDA Commissioner Margaret Hamburg from U.S. Senators Bob Corker and Lamar Alexander, both R-Tenn.

http://www.corker.senate.gov/public/?a=Files.Serve&File_id=37a64d36-12da-47da-a72a-cae11f382ae0